Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/ml has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viraemia are associated with virological rebound (VR) after virological suppression.
Armenia, D., Di Carlo, D., Cozzi-Lepri, A., Calcagno, A., Borghi, V., Gori, C., et al. (2019). Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. ANTIVIRAL THERAPY, 24(5), 321-331 [10.3851/IMP3309].
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen
Bertoli, Ada;Andreoni, Massimo;Ceccherini-Silberstein, Francesca;Perno, Carlo F;Santoro, Maria M
2019-04-12
Abstract
Pre-cART (combined antiretroviral therapy) plasma viral load >500,000 copies/ml has been associated with a lower probability of achieving virological suppression, while few data about its role on maintenance of virological suppression are available. In this study we aimed to clarify whether high levels of pre-cART viraemia are associated with virological rebound (VR) after virological suppression.| File | Dimensione | Formato | |
|---|---|---|---|
|
2019_Antivir Ther_Armenia et al _Impact of pre therapyVL on VR.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Copyright dell'editore
Dimensione
381.38 kB
Formato
Adobe PDF
|
381.38 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
